Lung Cancer
A Phase 1/2 Study of Avutometinib in Combination with Sotorasib with or without Defactinib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)
- Details
ClinicalTrials.gov ID:
NCT05074810
Diagnosis Type:
NA
USOR Number:
- Address
,
P: